Serum Hypophosphatemia in Tenofovir Disoproxil Fumarate Recipients is Multifactorial in Origin, Questioning the Utility of its Monitoring in Clinical Practice

Day, S.L., Leake Date, H.A., Fisher, M., Bannister, A. and Hankins, M. (2005) Serum Hypophosphatemia in Tenofovir Disoproxil Fumarate Recipients is Multifactorial in Origin, Questioning the Utility of its Monitoring in Clinical Practice. Journal of Acquired Immune Deficiency Syndromes, 38 (3). pp. 301-304. ISSN 1077-9450

[img] PDF
Restricted to SRO admin only

Download (70kB)

Abstract

Summary: Tenofovir disoproxil fumarate (TDF) has been anecdotally associated with isolated hypophosphatemia (HP) as well as proximal tubular toxicity and renal dysfunction in which HP has consistently been a feature. Consequently, routine phosphate measurements in TDF recipients have been recommended. We identified and compared the frequency of HP in TDF recipients with that in non-TDF recipients; assessed the reproducibility of HP; identified the incidence of renal dysfunction in hypophosphatemic patients; and evaluated associations between HP and host, HIV infection, or treatment factors. This prospective observational study measured serum phosphate, urea, and creatinine in HIV-positive individuals among the following treatment groups: TDF-containing highly active antiretroviral therapy (HAART, group A), TDF-sparing HAART (group B), HAART naive (group C), and off HAART but treatment experienced (group D). Phosphate measurements were obtained in 252 patients. Seventy-two percent of patients prescribed TDF received a phosphate measurement. The frequency of HP in groups A, B, C, and D was 31%, 22%, 10%, and 14%, respectively. Seventy-eight percent of phosphate measurements were reproducible. Kaletra (P = 0.016) administration and duration of antiretroviral therapy (P = 0.023) were independently associated with HP, but elevated creatinine and urea or use of TDF was not. The etiology of HP seems to be multifactorial and unrelated to TDF or renal dysfunction. This questions the utility of routine phosphate testing, in isolation, in TDF recipients.

Item Type: Article
Schools and Departments: Brighton and Sussex Medical School > Primary Care and Public Health
Depositing User: Jane Harle
Date Deposited: 24 Oct 2008
Last Modified: 13 Mar 2017 11:58
URI: http://sro.sussex.ac.uk/id/eprint/2046
Google Scholar:32 Citations

View download statistics for this item

📧 Request an update